OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
52
Results
Show all
Save search
Copy query
Show results for
Unknown
(52)
Publication Date
Release Date
2021
(11)
2022
(7)
2020
(6)
2025
(5)
2016
(5)
2019
(3)
2015
(3)
2014
(3)
2023
(2)
2013
(2)
2026
(1)
2024
(1)
2018
(1)
2012
(1)
2011
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen
®
and the monomeric TLR5 ligand FliC in zebu cattle against AlHV-1 malignant catarrhal fever induced by experimental virus challenge.
Not available
S-EPMC5081063
|
biostudies-literature
Cite
A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.
Not available
S-EPMC4742522
|
biostudies-literature
Cite
Alcelaphine Herpesvirus-1 (Malignant Catarrhal Fever Virus) in Wildebeest Placenta: Genetic Variation of ORF50 and A9.5 Alleles.
Not available
S-EPMC4430166
|
biostudies-literature
Cite
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.
Not available
S-EPMC4951150
|
biostudies-literature
Cite
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
Not available
S-EPMC6405334
|
biostudies-literature
Cite
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis.
Not available
S-EPMC12928530
|
biostudies-literature
Cite
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Not available
S-EPMC7545591
|
biostudies-literature
Cite
Equitable Expanded Carrier Screening Needs Indigenous Clinical and Population Genomic Data.
Not available
S-EPMC7413856
|
biostudies-literature
Cite
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial.
Not available
S-EPMC4264937
|
biostudies-literature
Cite
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets